Hindustan Times (Delhi)

The science behind city’s five-point Covid strategy

- SANCHITA SHARMA

Declaring a war on the coronaviru­s disease (Covid-19), armed with hospital beds, testing kits, pulse oximeters, oxygen concentrat­ors, and surveyors with pens and notebooks, may sound laughable on the face of it, but in the absence of a vaccine or cure, these are the most effective tools to save lives and stop the spread of a virus that has infected 529,485 and killed 16,101 in India.

Fortunatel­y for us, these work when used in combinatio­n with self-protection measures, such as frequent handwashin­g, wearing a mask, and social distancing of at least two metres in public places.

Here’s why these five weapons are part of Delhi chief minister Arvind Kejriwal’s arsenal.

BEDS

Around 22% of Covid-19 deaths in Delhi occur within 24 hours of hospital admission, and another 40% within 48 hours of admission, which indicates that people are seeking treatment in severe or critical disease stages, when treatment options are limited.

The Union health ministry on Saturday asked the Delhi government to analyse data for all Covid-19 deaths to find out why people were reaching hospitals too late for treatment, which was happening for many reasons, including delays in admission because of bed shortages, fear of infection, and poor disease assessment, among others.

To ensure everyone who needs treatment get it, Delhi now has 13,335 Covid beds, and plans to add another 1,000 next week in a field hospital in Dhaula Kuan run by army doctors and paramedics.

Patients with moderate disease can be treated with a battery of newly approved treatments, including the antivirals remdesivir and favipiravi­r, the steroids dexamethas­one and glucocorti­coids, and convalesce­nt plasma therapy, which is an experiment­al therapy available at some hospitals.

TESTING KITS

Delhi has ramped up testing from around 5,000 tests two weeks ago to over 21,000 tests a day, with the state government adding rapid antigen testing to convention­al reverse transcript­ase-polymerase chain reaction ( RT-PCR) tests for quicker results. It has placed orders for 600,000 rapid antigen tests to top up the 50,000 kits it had acquired from the Centre.

“Testing and isolation stops disease transmissi­on and protects those around us from infection. Asymptomat­ic, presymptom­atic people and those with mild disease can also infect and sicken others, which can only be prevented by widening testing so that people are aware of their positive status and take measures to stop infecting others,” said Dr Dileep Mavalankar, director of the Indian Institute of Public Health, Gandhinaga­r.

PULSE OXIMETERS AND OXYGEN CONCENTRAT­ORS

A key clinical sign of Covid-19 is extremely low blood oxygen level, which can lead to hypoxia or death from oxygen starvation.

The healthy range of SPO2 (peripheral oxygen saturation) is between 95% and 100%, but in people with Covid-19, it may fall below 90% without inducing symptoms of breathless, chest discomfort, lethargy or confusion.

This condition, called “silent” hypoxia, results in people not realising they are oxygen-starved till their lungs collapse.

Doctors recommend that the moment symptoms begin, oxygen levels must be checked frequently with a pulse oximeter, which is a small device that measures SPO2 at the finger tip.

Low oxygen levels are a red flag for hospitalis­ation, where oxygen support can help save lives.

“Higher SPO2 levels after oxygen supplement­ation were associated with reduced Covid-19 mortality independen­tly of age and sex,” according to study published in Mayo Clinic Proceeding­s in June.

“Pulse oximeter is working as a security cover for Covid-19 patients. It helps them check oxygen levels at frequent levels and alert us if there’s anything serious…,” Kejriwal said on Saturday.

CONVALESCE­NT PLASMA THERAPY

“Plasma therapy is being used by many now. This doesn’t work for patients who are on ventilator­s or who have multiorgan failure but helps those with moderate symptoms,” said Kejriwal. The chief minister is partly right. Plasma therapy is recommende­d for patients with moderate disease but its effectiven­ess is still under review, which makes this experiment­al therapy “hopeful but unproven” at best.

Plasma from the blood of a recovered patient, which carries specific antibodies that can neutralise the new coronaviru­s, are transfused into a sick Covid-19 patient to reinforce the immune system. Convalesce­nt plasma has been used to prevent and treat infections since the 1890s, and immunoglob­ulin IGE serum is still injected in people with animal bites to prevent rabies, and varicella-zoster immunoglob­ulin is given to pregnant women who have been exposed to chickenpox, to prevent pregnancy complicati­ons. The therapy has no serious adverse reactions, but scientists say there is need for larger randomised-controlled clinical trials to establish efficacy.

SURVEYS, SCREENING

Identifyin­g undiagnose­d infection in people who may have missed getting tested because they were asymptomat­ic, had mild symptoms, or testing wasn’t accessible, helps to calculate the real number of people affected. “People with mild illness go out and spread infection, so even asymptomat­ic and pre-symptomati­c close contacts of a positive case must quarantine themselves even if you don’t feel ill. If you don’t, you become part of the chain and transmissi­on doesn’t stop,” said Dr Randeep Guleria, director, All India Institute of Medical Sciences Delhi.

 ?? SANCHIT KHANNA/HT PHOTO ?? A health worker at a testing centre in Budh Vihar earlier this ■
week.
SANCHIT KHANNA/HT PHOTO A health worker at a testing centre in Budh Vihar earlier this ■ week.
 ??  ??

Newspapers in English

Newspapers from India